Early Efficacy of Tamsulosin Versus Terazosin in the Treatment of Men With Benign Prostatic Hyperplasia : A Randomized , Open-Label Trial

@inproceedings{Narayan2005EarlyEO,
  title={Early Efficacy of Tamsulosin Versus Terazosin in the Treatment of Men With Benign Prostatic Hyperplasia : A Randomized , Open-Label Trial},
  author={Perinchery Narayan and Michael P. O’Leary and Giora Davidai},
  year={2005}
}
Background: We evaluated the efficacy and tolerability of tamsulosin versus terazosin in patients with signs and symptoms of benign prostatic hyperplasia (BPH). Methods: Patients (N = 1,993) were randomized to tamsulosin (0.4 mg/day) or terazosin (5 mg/day, following titration). The primary efficacy endpoint was total American Urological Association Symptom Index (AUA-SI) score after 4 days of treatment. Secondary endpoints were score changes on measures of BPH symptoms and other clinical… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

References

Publications referenced by this paper.
Showing 1-10 of 18 references

Similar Papers

Loading similar papers…